Involved in N-glycan biogenesis, conserved eukaryotic protein.. Localization: ER (by homology)
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 5 |
GO:0110165 | cellular anatomical entity | 1 | 5 |
Related structures:
AlphaFold database: Q4Q7R8
Term | Name | Level | Count |
---|---|---|---|
GO:0006486 | protein glycosylation | 4 | 6 |
GO:0006487 | protein N-linked glycosylation | 5 | 6 |
GO:0006629 | lipid metabolic process | 3 | 2 |
GO:0006793 | phosphorus metabolic process | 3 | 2 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 6 |
GO:0008152 | metabolic process | 1 | 9 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016311 | dephosphorylation | 5 | 2 |
GO:0019538 | protein metabolic process | 3 | 6 |
GO:0030258 | lipid modification | 4 | 2 |
GO:0036211 | protein modification process | 4 | 6 |
GO:0043170 | macromolecule metabolic process | 3 | 6 |
GO:0043412 | macromolecule modification | 4 | 6 |
GO:0043413 | macromolecule glycosylation | 3 | 6 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 9 |
GO:0044255 | cellular lipid metabolic process | 3 | 2 |
GO:0046839 | phospholipid dephosphorylation | 5 | 2 |
GO:0070085 | glycosylation | 2 | 6 |
GO:0071704 | organic substance metabolic process | 2 | 9 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 9 |
GO:0016462 | pyrophosphatase activity | 5 | 6 |
GO:0016787 | hydrolase activity | 2 | 9 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 5 |
GO:0016791 | phosphatase activity | 5 | 5 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 3 | 6 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 4 | 6 |
GO:0042392 | sphingosine-1-phosphate phosphatase activity | 7 | 2 |
GO:0042577 | lipid phosphatase activity | 6 | 2 |
GO:0042578 | phosphoric ester hydrolase activity | 4 | 5 |
GO:0047874 | dolichyldiphosphatase activity | 6 | 6 |
GO:0008195 | phosphatidate phosphatase activity | 6 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 167 | 169 | PF00675 | 0.264 |
CLV_NRD_NRD_1 | 173 | 175 | PF00675 | 0.271 |
CLV_NRD_NRD_1 | 181 | 183 | PF00675 | 0.154 |
CLV_NRD_NRD_1 | 99 | 101 | PF00675 | 0.375 |
CLV_PCSK_FUR_1 | 165 | 169 | PF00082 | 0.286 |
CLV_PCSK_FUR_1 | 97 | 101 | PF00082 | 0.388 |
CLV_PCSK_KEX2_1 | 167 | 169 | PF00082 | 0.303 |
CLV_PCSK_KEX2_1 | 173 | 175 | PF00082 | 0.307 |
CLV_PCSK_KEX2_1 | 181 | 183 | PF00082 | 0.154 |
CLV_PCSK_KEX2_1 | 99 | 101 | PF00082 | 0.375 |
CLV_PCSK_SKI1_1 | 247 | 251 | PF00082 | 0.342 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.414 |
DEG_SPOP_SBC_1 | 192 | 196 | PF00917 | 0.486 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 101 | 110 | PF00134 | 0.531 |
DOC_CYCLIN_yCln2_LP_2 | 257 | 263 | PF00134 | 0.450 |
DOC_MAPK_gen_1 | 97 | 106 | PF00069 | 0.537 |
DOC_MAPK_MEF2A_6 | 99 | 108 | PF00069 | 0.502 |
DOC_PP1_RVXF_1 | 6 | 12 | PF00149 | 0.417 |
DOC_USP7_MATH_1 | 134 | 138 | PF00917 | 0.286 |
DOC_USP7_MATH_1 | 185 | 189 | PF00917 | 0.514 |
DOC_USP7_MATH_1 | 190 | 194 | PF00917 | 0.423 |
DOC_USP7_MATH_1 | 39 | 43 | PF00917 | 0.544 |
DOC_USP7_MATH_1 | 75 | 79 | PF00917 | 0.258 |
DOC_WW_Pin1_4 | 123 | 128 | PF00397 | 0.296 |
DOC_WW_Pin1_4 | 193 | 198 | PF00397 | 0.579 |
LIG_14-3-3_CanoR_1 | 247 | 252 | PF00244 | 0.573 |
LIG_Actin_WH2_2 | 105 | 123 | PF00022 | 0.464 |
LIG_BRCT_BRCA1_1 | 70 | 74 | PF00533 | 0.344 |
LIG_DCNL_PONY_1 | 1 | 4 | PF03556 | 0.347 |
LIG_EH1_1 | 73 | 81 | PF00400 | 0.386 |
LIG_eIF4E_1 | 198 | 204 | PF01652 | 0.464 |
LIG_eIF4E_1 | 64 | 70 | PF01652 | 0.444 |
LIG_FHA_1 | 206 | 212 | PF00498 | 0.368 |
LIG_FHA_1 | 240 | 246 | PF00498 | 0.407 |
LIG_FHA_1 | 266 | 272 | PF00498 | 0.542 |
LIG_FHA_1 | 4 | 10 | PF00498 | 0.417 |
LIG_FHA_1 | 58 | 64 | PF00498 | 0.433 |
LIG_FHA_2 | 38 | 44 | PF00498 | 0.498 |
LIG_FHA_2 | 45 | 51 | PF00498 | 0.431 |
LIG_LIR_Apic_2 | 139 | 145 | PF02991 | 0.314 |
LIG_LYPXL_SIV_4 | 197 | 205 | PF13949 | 0.514 |
LIG_NRBOX | 199 | 205 | PF00104 | 0.464 |
LIG_Pex14_2 | 151 | 155 | PF04695 | 0.362 |
LIG_RPA_C_Fungi | 27 | 39 | PF08784 | 0.679 |
LIG_SH2_CRK | 142 | 146 | PF00017 | 0.405 |
LIG_SH2_CRK | 220 | 224 | PF00017 | 0.351 |
LIG_SH2_NCK_1 | 138 | 142 | PF00017 | 0.386 |
LIG_SH2_NCK_1 | 198 | 202 | PF00017 | 0.464 |
LIG_SH2_STAP1 | 138 | 142 | PF00017 | 0.393 |
LIG_SH2_STAP1 | 198 | 202 | PF00017 | 0.396 |
LIG_SH2_STAT5 | 109 | 112 | PF00017 | 0.410 |
LIG_SH2_STAT5 | 13 | 16 | PF00017 | 0.596 |
LIG_SH2_STAT5 | 138 | 141 | PF00017 | 0.410 |
LIG_SH2_STAT5 | 158 | 161 | PF00017 | 0.362 |
LIG_SH3_3 | 121 | 127 | PF00018 | 0.379 |
LIG_SH3_3 | 253 | 259 | PF00018 | 0.457 |
LIG_SUMO_SIM_par_1 | 202 | 208 | PF11976 | 0.230 |
LIG_TYR_ITIM | 107 | 112 | PF00017 | 0.410 |
LIG_WRC_WIRS_1 | 263 | 268 | PF05994 | 0.516 |
MOD_CDK_SPK_2 | 123 | 128 | PF00069 | 0.362 |
MOD_CK1_1 | 137 | 143 | PF00069 | 0.365 |
MOD_CK1_1 | 193 | 199 | PF00069 | 0.443 |
MOD_CK1_1 | 42 | 48 | PF00069 | 0.679 |
MOD_CK2_1 | 14 | 20 | PF00069 | 0.596 |
MOD_CK2_1 | 37 | 43 | PF00069 | 0.635 |
MOD_CK2_1 | 44 | 50 | PF00069 | 0.558 |
MOD_CMANNOS | 54 | 57 | PF00535 | 0.506 |
MOD_Cter_Amidation | 171 | 174 | PF01082 | 0.304 |
MOD_GlcNHglycan | 16 | 19 | PF01048 | 0.596 |
MOD_GlcNHglycan | 175 | 178 | PF01048 | 0.435 |
MOD_GlcNHglycan | 183 | 186 | PF01048 | 0.405 |
MOD_GlcNHglycan | 187 | 190 | PF01048 | 0.449 |
MOD_GlcNHglycan | 92 | 95 | PF01048 | 0.423 |
MOD_GSK3_1 | 181 | 188 | PF00069 | 0.445 |
MOD_GSK3_1 | 37 | 44 | PF00069 | 0.698 |
MOD_NEK2_1 | 110 | 115 | PF00069 | 0.410 |
MOD_NEK2_1 | 136 | 141 | PF00069 | 0.328 |
MOD_NEK2_1 | 205 | 210 | PF00069 | 0.245 |
MOD_NEK2_1 | 238 | 243 | PF00069 | 0.404 |
MOD_NEK2_1 | 262 | 267 | PF00069 | 0.504 |
MOD_NEK2_1 | 3 | 8 | PF00069 | 0.605 |
MOD_NEK2_1 | 74 | 79 | PF00069 | 0.362 |
MOD_NEK2_2 | 153 | 158 | PF00069 | 0.426 |
MOD_PKA_1 | 173 | 179 | PF00069 | 0.431 |
MOD_PKA_1 | 181 | 187 | PF00069 | 0.219 |
MOD_PKA_2 | 173 | 179 | PF00069 | 0.436 |
MOD_PKA_2 | 181 | 187 | PF00069 | 0.257 |
MOD_Plk_1 | 42 | 48 | PF00069 | 0.537 |
MOD_Plk_4 | 205 | 211 | PF00069 | 0.374 |
MOD_Plk_4 | 262 | 268 | PF00069 | 0.489 |
MOD_Plk_4 | 75 | 81 | PF00069 | 0.328 |
MOD_ProDKin_1 | 123 | 129 | PF00069 | 0.362 |
MOD_ProDKin_1 | 193 | 199 | PF00069 | 0.478 |
TRG_DiLeu_BaEn_1 | 5 | 10 | PF01217 | 0.531 |
TRG_ENDOCYTIC_2 | 109 | 112 | PF00928 | 0.410 |
TRG_ENDOCYTIC_2 | 13 | 16 | PF00928 | 0.596 |
TRG_ENDOCYTIC_2 | 220 | 223 | PF00928 | 0.351 |
TRG_ER_diArg_1 | 165 | 168 | PF00400 | 0.369 |
TRG_ER_diArg_1 | 99 | 101 | PF00400 | 0.471 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IGH8 | Leptomonas seymouri | 54% | 100% |
A0A1X0P264 | Trypanosomatidae | 36% | 100% |
A0A3S7X373 | Leishmania donovani | 88% | 100% |
A0A422NMI8 | Trypanosoma rangeli | 35% | 100% |
A4HHZ1 | Leishmania braziliensis | 78% | 100% |
A4I568 | Leishmania infantum | 89% | 100% |
B0CM95 | Papio anubis | 31% | 100% |
B0KWE9 | Callithrix jacchus | 31% | 100% |
B1MTH4 | Plecturocebus moloch | 31% | 100% |
B2KI79 | Rhinolophus ferrumequinum | 31% | 100% |
C9ZQJ4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 31% | 100% |
E9B0G5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
Q86IX2 | Dictyostelium discoideum | 29% | 100% |
Q86YN1 | Homo sapiens | 31% | 100% |
Q9JMF7 | Mus musculus | 30% | 100% |